Federal Contracting Intelligence
Recompete Radar
Recompete Radar · NAICS

NAICS 541711 — Research and Development in Biotechnology

Federal contracts classified under NAICS 541711 whose current period of performance ends in the next 24 months.

5 contracts · $12,075M total

5 contracts

  • CERUS CORPORATIONSB
    CERUS - DEVELOPMENT AND IMPLEMENTATION OF PATHOGEN REDUCTION TECHNOLOGY (PRT).
    $185.2M
    Mar 31, 2027
    FY27 Q2 · 5 mo
    Office of Assistant Secretary for Preparedness and Response · NAICS 541711Record
  • THE EMMES COMPANY, LLCSB
    DATA COORDINATING CENTER FOR THE BEST PHARMACEUTICALS FOR CHILDREN ACT
    $66.0M
    May 28, 2027
    FY27 Q3 · 7 mo
    National Institutes of Health · NAICS 541711Record
  • REGENERON PHARMACEUTICALS INC
    - REGENERON OTHER TRANSACTION AUTHORITY (OTA) AWARD
    $278.8M
    Sep 25, 2027
    FY27 Q4 · 11 mo
    Office of Assistant Secretary for Preparedness and Response · NAICS 541711Record
  • MERCK SHARP & DOHME LLC
    $236.3M
    Sep 27, 2027
    FY27 Q4 · 11 mo
    Office of Assistant Secretary for Preparedness and Response · NAICS 541711Record
  • ALLIANCE FOR ENERGY INNOVATION, LLC
    AWARD OF CONTRACT TO MANAGE AND OPERATE THE NATIONAL RENEWABLE ENERGY LABORATORY
    $11.3B
    Sep 30, 2028
    FY28 Q4 · 23 mo
    Department of Energy · NAICS 541711Record

“Current end” is the end of the current period of performance in USAspending. Unexercised options can extend a contract, and agencies may recompete early or late — treat these dates as the start of your research, not a schedule.

Track these every week

The Small Business Wire lands every Monday with new awards and upcoming recompetes in your NAICS codes. Free.

Free. A focused briefing on federal contracting. Unsubscribe anytime.